Nantahala Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Nantahala Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-648,885	Closed	-$1.91M	–	156
2026 Q1	$1.91M	Hold	648,885	–	–	0.07%	136
2025 Q4	$3.22M	Hold	648,885	–	–	0.11%	117
2025 Q3	$2.04M	Sell	648,885 -250,000	-28%	-$686K	0.07%	132
2025 Q2	$2.03M	Hold	898,885	–	–	0.08%	125
2025 Q1	$2.4M	Buy	898,885 +244,885	+37%	+$762K	0.1%	109
2024 Q4	$2.3M	Hold	654,000	–	–	0.1%	105
2024 Q3	$3.1M	Hold	654,000	–	–	0.16%	90
2024 Q2	$3.07M	Hold	654,000	–	–	0.18%	81
2024 Q1	$2.97M	Buy	+654,000	New	+$2.9M	0.17%	82

Other funds holding ACHV

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nantahala Capital Management's ACHV Position: Q2 2026 in Review

Nantahala Capital Management sold out of Achieve Life Sciences (ACHV) in Q2 2026, closing a stake of 648,885 shares — an estimated $1.91M sold.

Nantahala Capital Management first reported a position in ACHV in Q1 2024 and held it in 9 quarters. The position peaked at $3.22M in Q4 2025. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

Nantahala Capital Management reported no remaining Achieve Life Sciences position as of Q2 2026 after selling out during the quarter.
Nantahala Capital Management sold 648,885 Achieve Life Sciences shares in Q2 2026, an estimated $1.91M.
Nantahala Capital Management first reported a position in Achieve Life Sciences in Q1 2024 and held it in 9 quarters.
Nantahala Capital Management's Achieve Life Sciences position peaked at $3.22M in Q4 2025.
111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.